Addus HomeCare (ADUS)
(Delayed Data from NSDQ)
$121.38 USD
+2.56 (2.15%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $121.27 -0.11 (-0.09%) 6:42 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ADUS 121.38 +2.56(2.15%)
Will ADUS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ADUS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADUS
Can Centene (CNC) Navigate Falling Memberships in Q2 Earnings?
Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?
ADUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog Highlights DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant
Top 5 Outpatient and Home Healthcare Stocks for Solid Returns
Compared to Estimates, Addus HomeCare (ADUS) Q1 Earnings: A Look at Key Metrics
Other News for ADUS
Addus HomeCare Announces Second Quarter 2024 Earnings Release and Conference Call
Addus HomeCare Announces Closing of Public Offering
RBC says presidential debate bodes well for managed care stocks
Addus Homecare (ADUS) Receives a Buy from Bank of America Securities
Addus HomeCare initiated with bullish view at Macquarie, here's why